Beyond Air (NASDAQ:XAIR) Cut to “Sell” at Wall Street Zen

Wall Street Zen lowered shares of Beyond Air (NASDAQ:XAIR) from a hold rating to a sell rating in a report issued on Saturday.

A number of other research analysts have also recently issued reports on XAIR. D Boral Capital raised shares of Beyond Air to a “strong-buy” rating in a research report on Thursday, July 17th. D. Boral Capital reissued a “buy” rating and set a $11.00 price target on shares of Beyond Air in a research report on Wednesday, August 13th.

Beyond Air Trading Up 3.4%

NASDAQ:XAIR opened at $2.40 on Friday. The company has a 50-day moving average price of $3.39 and a 200-day moving average price of $4.51. Beyond Air has a 12 month low of $2.22 and a 12 month high of $13.52. The company has a current ratio of 3.24, a quick ratio of 2.71 and a debt-to-equity ratio of 0.92. The stock has a market cap of $12.55 million, a price-to-earnings ratio of -0.20 and a beta of 0.25.

Beyond Air (NASDAQ:XAIR) last posted its earnings results on Tuesday, August 12th. The company reported ($1.53) EPS for the quarter, missing the consensus estimate of ($1.50) by ($0.03). Beyond Air had a negative return on equity of 232.61% and a negative net margin of 880.72%. The company had revenue of $1.76 million during the quarter, compared to analysts’ expectations of $1.75 million. Equities analysts predict that Beyond Air will post -0.79 EPS for the current year.

Institutional Trading of Beyond Air

Institutional investors and hedge funds have recently bought and sold shares of the company. XTX Topco Ltd bought a new stake in shares of Beyond Air in the first quarter worth approximately $31,000. Wealth Effects LLC raised its position in Beyond Air by 42.5% in the second quarter. Wealth Effects LLC now owns 278,100 shares of the company’s stock worth $48,000 after acquiring an additional 83,000 shares during the period. Squarepoint Ops LLC purchased a new position in shares of Beyond Air during the 4th quarter worth $48,000. Wealthedge Investment Advisors LLC purchased a new position in shares of Beyond Air during the 4th quarter worth $80,000. Finally, Geode Capital Management LLC boosted its stake in shares of Beyond Air by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 838,319 shares of the company’s stock worth $144,000 after acquiring an additional 12,598 shares during the last quarter. 31.50% of the stock is currently owned by institutional investors.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.